The Queen's Partnerships and Innovation (QPI) team develops and facilitates partnerships with industry, governments, not-for-profit organizations, and other academic institutions to advance the research enterprise at Queen鈥檚 and the commercialization and protection of inventions, and to strengthen the regional innovation ecosystem in Kingston and Eastern Ontario.
The QPI team supports the University鈥檚 strategic goal to build community partnerships and fully embed Queen鈥檚 in the community. With support from external funding, the QPI team offers numerous services, resources, and programs to support entrepreneurs, including those from Queen鈥檚, and to accelerate the growth of startups and small- to medium-sized enterprises (SMEs) within Kingston and Eastern Ontario.
More than 100,000 Canadians live with Parkinson鈥檚 and 25 more are diagnosed every day. A diagnosis for Parkinson鈥檚, a neurodegenerative disease, may take months, or even years, of searching for answers to seemingly unexplainable symptoms ().
A newly formed company in Kingston is using Queen鈥檚 University鈥檚 researcher Doug Munoz鈥檚 innovative solution to make a diagnosis of neurodegenerative diseases like Parkinson鈥檚 more quickly and accurately. Dynamiris is developing a fast, objective, and low-cost tool that clinicians can implement right in their office to flag patients earlier for further testing, which can then lead to earlier treatment and better outcomes for patients.
Queen鈥檚 Partnerships and Innovation (QPI) drafted and filed a first patent application in 1999 for Professor Munoz, for which a United States patent was granted in 2001. Since that time, Dr. Munoz and his research team have continued to develop more intellectual property, and QPI drafted, filed, and prosecuted a second patent application for which another United States patent was granted in 2014. In 2022, QPI drafted and filed an international patent application under the Patent Cooperation Treaty (PCT) for Dr. Munoz鈥檚 eye tracking technology for detecting brain disorders.
Dr. Munoz credits the shut-down of the pandemic with how quickly they were able to accelerate aspects of the eye tracking technology.
鈥淲ith everything shut down and everyone at home, it gave us time to build new analysis pipelines and analyze data to find critical data markers,鈥 says Dr. Munoz. 鈥淔rom the data we have collected from patients and animal subjects, we have been able to get important behavioural information from eye-tracking, which has in turn helped to create an algorithm for identifying diseases. I鈥檓 not sure we would have been here as fast if not for the extra time to analyze the data.鈥
鈥淲e saw the market potential for the research that Dr. Munoz was working on,鈥 says Michael Wells, Partnerships Development Officer (Health and Life Sciences) with QPI. 鈥淪o, when an opportunity to collaborate with the Toronto Innovation Acceleration Partners came up, we knew that Dr. Munoz鈥檚 technology would be a great fit.鈥
The is a not-for-profit organization with a mandate to bring members鈥 most promising research breakthroughs to market. TIAP offers a suite of programs and funding to help inventors advance their innovations. In 2020, TIAP invited Queen鈥檚 to join its new Venture Builder Program, an initiative led by TIAP with funding from the Federal Economic Development Agency of Southern Ontario (FDO). This funding, combined with the requisite matching contribution from Queen鈥檚, has enabled QPI to encourage, support, and guide the establishment and launch of three health-care companies to commercialize intellectual property assigned to Queen鈥檚. Dynamiris is one of the startups that is benefitting from QPI鈥檚 guidance and networks, and an initial investment made possible by the FDO funding. Dr. Wells leads the TIAP Venture Builder Program at Queen鈥檚.
鈥淢ichael Wells has been instrumental in getting us to the starting line. He has shown tremendous patience with the mentoring of getting us to this point,鈥 says Dr. Munoz.
In the short amount of time since incorporating, Dynamiris has seen some early success.
The first step in bringing the technology to market through the Venture Builder Program was for Dr. Munoz to bring on a partner who could work full-time on developing and incorporating the company. Dr. Janis Kan, a Queen鈥檚 University neuroscience PhD graduate joined as co-founder of Dynamiris.
In May 2022, Dr. Kan took home the top prize of $5,000 (sponsored by and supported by Queen鈥檚 Faculty of Engineering and Applied Science) at the Mitacs Invention to Innovation (i2i) Skills Training Final Pitch Competition. Dynamiris has also been busy making connections through QPI. A recent participant in the Wings Acceleration program, that spanned the late spring and early summer, Dr. Kan credits the program with helping her better understand and identify differentiators, and how to apply them to the business.
Wings is aimed at startups in the early, pre-revenue, stages of development. The Wings facilitators give startup founders the tools and guidance they need to evaluate the feasibility of their business idea, determine what they really have to offer customers, and begin developing a working business model.
鈥淭he program helped reiterate the importance of doing customer interviews, how to ask appropriate questions, and gave me ideas on how to reach out to customers,鈥 adds Dr. Kan.
Dr. Kan has also tapped into the resources made available through other QPI projects and initiatives, including QPI鈥檚 Go-to-Market programs and services, and the WE-CAN Project at Queen鈥檚 University. The Konnect program, offered by the Dunin-Deshpande Queen鈥檚 Innovation Centre as part of the WE-CAN Project, provided Dr. Kan with an additional network, support system, and personal and professional development opportunities.
As for next steps, Dynamiris is continuing to develop the technology and tools through which to deliver their eye tracking protocols. They plan to recruit more patients 鈥 as the more data they have, the more accurate the algorithm becomes 鈥 and they continue to set up the company with the aim of fully commercializing the product.
鈥淚deally we can create a fully automated process,鈥 says Dr. Kan. 鈥淚f we can build the program prototype and get it into doctors鈥 offices, we can hopefully deliver same day results. It could be a game-changer for patient diagnoses.鈥
鈥淒ynamiris is a great example of how all of our ecosystem projects that receive support from FedDev Ontario 鈥 the Scale-Up Platform, HI YGK, WE-CAN, and Venture Builder 鈥 work together synergistically to help build and grow a company,鈥 says Janice Mady, Director, Research and Innovation Partnerships with QPI. 鈥淔rom formation, incorporation, and the assembly of co-founders and a support structure using Venture Builder resources, to customer discovery and market validation using Scale-Up resources, to mentorship and Go-to-Market support through HI-YGK, and networking through WE-CAN, Dynamiris has been able to tap into numerous complementary supports, providing it with a strong foundation for growth.鈥
Queen鈥檚 Partnerships and Innovation is involved as the lead or partner in several projects enabled with support from the . Wings is offered through the , an initiative supported by FedDev Ontario and led by Invest Ottawa in Eastern Ontario and in which QPI is a regional partner. The WE-CAN Project, led by QPI, has been made possible with funding from the to strengthen capacity within the entrepreneurship ecosystem and close gaps in service for women entrepreneurs. The , supported by FedDev Ontario, is led by the City of Kingston and aims to encourage health-innovation focused startups and SMEs to develop and grow in Kingston. The , also supported by FedDev Ontario, is led by TIAP and enables the establishment of up to four healthcare newcos that are commercializing intellectual property from Queen鈥檚 research.